• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[IIA型和IV型高脂蛋白血症患者的止血参数]

[Hemostatic parameters in patients with type IIA and IV hyperlipoproteinemia].

作者信息

Ferlito S, Torrisi A, Marangio S, Palermo A, Condorelli M, Mazzone D

机构信息

Cattedra di Metodologia Clinica Sistematica, Istituto di Clinica Medica I, Università di Catania.

出版信息

Minerva Cardioangiol. 1992 Jun;40(6):211-7.

PMID:1407615
Abstract

In order to assess the interrelationships between the lipemic and the haemostatic balance the Authors studied the behaviour of some thrombotic markers in hyperlipemic subjects. The series consists of 35 subjects (15 m, 20 f, mean age 56 +/- 9 years) suffering from primary polygenic hyperlipoproteinemia of type IIA (23 cases) and type IV (12 cases) (cholesterol and triglyceride values exceeding respectively 250 and 180 mg%); 38 control subjects matched for sex, age and body weight were also examined; all the subjects were without hepato-renal and endocrine-metabolic disorders as well as without clinical signs of arteriosclerotic vasculopathy. For each subject the Authors performed the assay of the fasting plasma levels of total cholesterol (TC), triglycerides (TG) (enzymatic methods), fibrinogen (F) (coagulometric method), factor VII (coagulometric method) (F VII), antithrombin III (AT III) (chromogenic method), tissue activator of plasminogen (tPA), beta-thromboglobulin (BTG) and D-dimer (D-D) (ELISA method). The type IIA hypercholesterolemic subjects showed a not significant trend in a thrombophilic sense of the markers (increase of F, F VII, BTG and D-D, decrease of AT III); the type IV hypertriglyceridemic subjects exhibited a significant (0.05) increase of factor VII, BTG and D-D compared to the control subjects.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

为了评估脂血症与止血平衡之间的相互关系,作者研究了高脂血症患者一些血栓形成标志物的变化情况。该研究系列包括35名受试者(15名男性,20名女性,平均年龄56±9岁),患有IIA型(23例)和IV型(12例)原发性多基因高脂蛋白血症(胆固醇和甘油三酯值分别超过250和180mg%);还检查了38名在性别、年龄和体重方面匹配的对照受试者;所有受试者均无肝肾和内分泌代谢紊乱,也无动脉硬化血管病变的临床体征。作者对每位受试者进行了空腹血浆总胆固醇(TC)、甘油三酯(TG)(酶法)、纤维蛋白原(F)(凝固法)、凝血因子VII(凝固法)(F VII)、抗凝血酶III(AT III)(发色法)、组织型纤溶酶原激活剂(tPA)、β-血小板球蛋白(BTG)和D-二聚体(D-D)(ELISA法)的检测。IIA型高胆固醇血症受试者的标志物在血栓形成倾向方面呈不显著趋势(F、F VII、BTG和D-D升高,AT III降低);IV型高甘油三酯血症受试者与对照受试者相比,凝血因子VII、BTG和D-D显著升高(P<0.05)。(摘要截短于250字)

相似文献

1
[Hemostatic parameters in patients with type IIA and IV hyperlipoproteinemia].[IIA型和IV型高脂蛋白血症患者的止血参数]
Minerva Cardioangiol. 1992 Jun;40(6):211-7.
2
[Prothrombotic and prethrombotic markers in obese diabetic and non-diabetic subjects].
Minerva Cardioangiol. 1991 Jan-Feb;39(1-2):21-8.
3
Haemostatic balance in patients with acute focal cerebral vasculopathy.急性局灶性脑血管病患者的止血平衡
Panminerva Med. 1994 Dec;36(4):184-7.
4
[The thrombophilic status and ischemic cardiopathy].
Minerva Cardioangiol. 1991 May;39(5):167-76.
5
[Hemostatic status in subjects with deep venous thrombosis].[深静脉血栓形成患者的止血状态]
Minerva Cardioangiol. 1996 Dec;44(12):649-53.
6
Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.亚临床甲状腺疾病中的血液凝固、纤溶活性和血脂谱:亚临床甲状腺功能亢进会增加血浆凝血因子X活性。
Clin Endocrinol (Oxf). 2006 Mar;64(3):323-9. doi: 10.1111/j.1365-2265.2006.02464.x.
7
Acute lipidemic effect of calcium heparin in normolipemic and hyperlipemic subjects.肝素钙对血脂正常和血脂异常受试者的急性脂质血症效应。
Int Angiol. 1989 Jul-Sep;8(3):140-4.
8
Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.原发性甲状旁腺功能亢进患者的血液凝固、纤维蛋白溶解和血脂谱:血浆因子VII和X活性及D-二聚体水平升高。
Exp Clin Endocrinol Diabetes. 2008 Nov;116(10):619-24. doi: 10.1055/s-2008-1065365. Epub 2008 May 16.
9
Alpha 2-antiplasmin, plasminogen activator inhibitor (PAI) and dilute blood clot lysis time in selected disease states.某些疾病状态下的α2-抗纤溶酶、纤溶酶原激活物抑制剂(PAI)及稀释血凝块溶解时间
Thromb Haemost. 1991 Nov 1;66(5):586-91.
10
Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.含50微克或30微克雌激素的口服避孕药引起的止血变量变化:对纤溶酶原激活物抑制物-1(PAI-1)活性无剂量依赖性影响。
Thromb Haemost. 1995 Sep;74(3):928-32.